Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ongoing clinical trials in systemic hypertension.

J Mann1, P Oddou

  • 1Speedel Group, Hirschgaesslein 11, 4051 Basel, Switzerland. jessica.mann@speedelgroup.com

Expert Opinion on Investigational Drugs
|January 5, 2002
PubMed
Summary

Hypertension remains a public health challenge, with many diagnosed patients undertreated or failing to reach blood pressure goals. New antihypertensive drugs offer potential, but their impact on long-term outcomes requires further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Compassion and Parenting in Mothers and Fathers with Depression.

Mindfulness·2016
Same author

Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Proliferating subcutaneous nodules in a 12-year-old girl.

Clinical and experimental dermatology·2015
Same author

Corrigendum: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.

Nature communications·2015
Same author

A national survey of Mohs micrographic surgery in the U.K.

The British journal of dermatology·2015
Same author

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.

Nature communications·2015

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Hypertension is a significant cardiovascular risk factor, particularly in older adults.
  • Despite available treatments, many diagnosed hypertension patients remain undertreated or do not achieve target blood pressure levels.
  • The increasing number of antihypertensive medications necessitates evaluation of their real-world impact.

Purpose of the Study:

  • To review the current landscape of hypertension treatment and management.
  • To discuss the challenges in achieving target blood pressure in treated patients.
  • To summarize ongoing and recent long-term morbidity and mortality trials comparing different antihypertensive drug classes.

Main Methods:

  • Literature review of hypertension epidemiology and treatment guidelines.

Related Experiment Videos

  • Analysis of trends in antihypertensive drug development and market availability.
  • Overview of comparative effectiveness trials for various pharmacological approaches.

    • Main Results:

    • A significant gap exists between diagnosed hypertension and adequately controlled blood pressure.
    • Many patients require multiple antihypertensive drugs to reach therapeutic goals.
    • Recent trials compare novel pharmacological classes against established treatments.

    Conclusions:

    • Effective hypertension management remains a critical public health goal.
    • Further research is needed to assess the long-term benefits of new antihypertensive therapies.
    • Comparative trials are essential for guiding optimal therapeutic strategies in hypertension.